Eucrates Biomedical Acquisition Corp. financial data

Location
250 West 55 Th Street, Suite 13 D, New York, NY
Fiscal year end
December 31
Latest financial report
10-K - Q4 2022 - Apr 13, 2023

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.21M shares -68.7%